Apollo Management Holdings L.P. Acquires Shares of 65,036 Alpha Teknova, Inc. (NASDAQ:TKNO)

Apollo Management Holdings L.P. acquired a new stake in Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 65,036 shares of the company's stock, valued at approximately $543,000. Apollo Management Holdings L.P. owned approximately 0.12% of Alpha Teknova as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also modified their holdings of the stock. JPMorgan Chase & Co. lifted its position in shares of Alpha Teknova by 622.5% during the 4th quarter. JPMorgan Chase & Co. now owns 4,400 shares of the company's stock worth $37,000 after buying an additional 3,791 shares during the last quarter. Mount Lucas Management LP acquired a new stake in shares of Alpha Teknova in the 4th quarter worth $75,000. China Universal Asset Management Co. Ltd. acquired a new stake in shares of Alpha Teknova in the 4th quarter valued at approximately $94,000. NewEdge Advisors LLC boosted its position in shares of Alpha Teknova by 14.3% during the 4th quarter. NewEdge Advisors LLC now owns 15,632 shares of the company's stock worth $131,000 after purchasing an additional 1,953 shares in the last quarter. Finally, Barclays PLC purchased a new stake in Alpha Teknova during the fourth quarter worth about $132,000. 13.81% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Craig Hallum assumed coverage on Alpha Teknova in a research report on Monday, February 10th. They issued a "buy" rating and a $12.00 price target for the company.

Alpha Teknova Trading Down 4.5 %

Shares of Alpha Teknova stock traded down $0.30 during mid-day trading on Monday, hitting $6.23. 122,226 shares of the stock were exchanged, compared to its average volume of 387,117. The company has a current ratio of 4.73, a quick ratio of 3.94 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $332.65 million, a price-to-earnings ratio of -8.41 and a beta of 0.54. The company has a 50-day simple moving average of $5.77 and a 200 day simple moving average of $7.13. Alpha Teknova, Inc. has a twelve month low of $1.15 and a twelve month high of $10.37.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last released its quarterly earnings data on Tuesday, March 4th. The company reported ($0.11) EPS for the quarter. The firm had revenue of $9.27 million for the quarter, compared to analyst estimates of $9.10 million. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. Research analysts forecast that Alpha Teknova, Inc. will post -0.58 EPS for the current year.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.